Related content

Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care?

By Mazhar Danish   Ali Nasim   Ngan Sarah  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 5-8

Future Medicine

Access to resources Recommend Favorite

Chemotherapy and cystectomy for muscle invasive bladder cancer

By Grossman H.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 463-463

Elsevier

Access to resources Recommend Favorite

Neoadjuvant M-VAC (Methotrexate, Vinblastine, Adriamycin, and Cisplatin) Chemotherapy and Bladder Preservation for Muscle-Infiltrating Transitional Cell Carcinoma of the Bladder

By Sternberg C.N.   Pansadoro V.   Lauretti S.   Platania A.   Giannarelli D.   Rossetti A.   De Carli P.   Arena M.G.   Cancrini A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 3, 1995-05 ,pp. : 127-133

Elsevier

Access to resources Recommend Favorite

Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer - a prospective study

By Knapp D.W.   Glickman N.W.   DeNicola D.B.   Bonney P.L.   Lin T.L.   Glickman L.T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 2, 2000-03 ,pp. : 47-59

Elsevier

Access to resources Recommend Favorite

Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder

By Poortmans Philip M.   Richaud Pierre   Collette Laurence   Ho Goey S.   Pierart Marianne   Van Der Hulst Marleen   Bolla Michel    

Acta Oncologica, Vol. 47, Iss. 5, 2008-11 ,pp. : 937-940

Informa Healthcare

Access to resources Recommend Favorite